Pharmaceutical Executive-02-01-2012

Issue PDF
Pharmaceutical Executive

February 01, 2012

Brand of the Year : Abbott's Humira

Pharmaceutical Executive
Column

February 01, 2012

For a rendering to be effective, the right balance must be struck between captivating art and accurate science.

Pharmaceutical Executive
Column

February 01, 2012

State tech transfer laws giving universities automatic ownership of employees' inventions represent a threat to pharma partnerships-but the Supreme Court is poised to intervene in the industry's favor.

Pharmaceutical Executive

February 01, 2012

Brazil's clinical trial research is the country's backbone.

Pharmaceutical Executive

Pharm Exec speaks to Bausch + Lomb CEO Brent Saunders about how he turned around "a very troubled company".

Pharmaceutical Executive
From the Editor

February 01, 2012

A new generation of products for inflammatory disease is coming forward, promising better promise and possibly a cure.

Pharmaceutical Executive
Country Report

February 01, 2012

Brazil was the last country to enter the fiscal crisis, but also the first to exit. And with a burgeoning middle class and a staunch commitment to national development, its pharmaceutical future is now.

Pharmaceutical Executive

Brazilian industry is learning to spread its pharma manufacturing around more.

Pharmaceutical Executive

After two years of waiting, FDA issued the first in a series of planned guidelines on social media at the end of last year. We look at some of the experts' reactions.

Pharmaceutical Executive

Sarah Krug asks if it is time for pharma companies to appoint a Chief Patient Officer, a new position designed to build an accord around patient trust.

Pharmaceutical Executive

February 01, 2012

Astellas makes its presence felt in Brazil.

Pharmaceutical Executive

February 01, 2012

French-based Besins is a relatively new entrant to the Brazilian pharma market.

Pharmaceutical Executive
Column

February 01, 2012

Will expanded markets and ACOs offset higher rebates, added fees, and closer scrutiny of marketing and prices?

Pharmaceutical Executive
Features

February 01, 2012

Pharm Exec's Brand of the Year: Abbott's Humira

Column
Pharmaceutical Executive

February 01, 2012

The EU's Innovative Medicines Initiative is helping to invigorate new drug development, but there are still many hurdles to tackle before its promise is realized.

Pharmaceutical Executive

Torrent's affiliate in Brazil has become the India-based company's biggest.

Pharmaceutical Executive
Column

February 01, 2012

Time to stop and think about CMS's 'Proposed Rule' on transparency and what it means for the life sciences business model.

Pharmaceutical Executive

Biominas helps foster the development of biotech-related businesses in Brazil.